moxifloxacin has been researched along with Respiratory Tract Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brashear, R; Nebesio, C; Nori, S; Travers, JB | 1 |
| Jones, RN | 1 |
1 review(s) available for moxifloxacin and Respiratory Tract Diseases
| Article | Year |
|---|---|
Moxifloxacin--a new fluoroquinolone antibacterial.
Topics: Anti-Bacterial Agents; Aza Compounds; Drug Administration Schedule; Drug Costs; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia; Quinolines; Randomized Controlled Trials as Topic; Respiratory Tract Diseases; Sinusitis | 2004 |
2 other study(ies) available for moxifloxacin and Respiratory Tract Diseases
| Article | Year |
|---|---|
Moxifloxacin-associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Drug Hypersensitivity; Fatal Outcome; Female; Fluoroquinolones; Humans; Liver Failure, Acute; Moxifloxacin; Quinolines; Respiratory Tract Diseases; Stevens-Johnson Syndrome | 2004 |
Conventional dogma applied to quinolones? Time for a change.
Topics: 4-Quinolones; Anti-Infective Agents; Aza Compounds; Clinical Trials as Topic; Fluoroquinolones; Gatifloxacin; Humans; Moxifloxacin; Outcome Assessment, Health Care; Pneumococcal Infections; Quinolines; Respiratory Tract Diseases; Streptococcus pneumoniae | 2001 |